FDA issues warning on use of azithromycin

03/13/2013 | Los Angeles Times (tiered subscription model) · Reuters

The FDA issued a warning that the antibiotic azithromycin, marketed as Zithromax or Zmax, could cause potentially fatal irregular heart rhythm in some patients. The agency said at-risk patients include those with a slower-than-normal heartbeat, with potassium or magnesium deficiencies, and those using medications to treat existing heart arrhythmia.

View Full Article in:

Los Angeles Times (tiered subscription model) · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID